CureVac NV

CVAC:NASDAQ

CureVac is a global clinical-stage biopharmaceutical company in the field of messenger RNA (mRNA) technology with expertise in developing and optimizing this versatile molecule for medical purposes. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases.

streetwise book logo Streetwise Company Fact Sheet

2024/4/23 1:31:01

(CVAC:NASDAQ)